Did you know the VA now covers Genelex testing for veterans? A recently approved contract is making pharmacogenetic testing accessible to clinicians in the Veterans Administration, so their patients can…
Read More
Everywhere we look, news about the epidemic of opiate abuse, both prescription and illicit, abounds. We hear about frightening statistics, celebrities and neighbors alike overdosing; even the availability of overdose…
Read More
An article published in JAMA Internal Medicine, April 2016 by Judy Jou, MA and Pamela Jo Johnson, MPH, PhD examined patterns of the use of complementary and alternative medicine (CAM),…
Read More
The care management team is perhaps one of the largest sources of investment for ACOs or any other organization transitioning to a value-based payment model. Therefore, it is critical that…
Read More
We’ve recently updated our Risk Analysis tool in YouScript to make it more useful for you! On the left side of the screen, you will see the Genetic Risk Stratification…
Read More
What if an underutilized type of genetic testing, combined with state-of-the-art software, could cut ER visits by more than half and reduce hospitalizations by one third? Now there is a…
Read More
On March 21, an article published online in JAMA Internal Medicine examined changes in the prevalence of medication use and the frequency of major drug-drug interactions. The study was authored…
Read More
In January 2015, President Obama announced the Precision Medicine Initiative, or PMI. The PMI was originally portioned $215 million in the 2016 budget, with the aim to use patient volunteered…
Read More
YouScript has received a fair amount of attention at HIMSS since we first began attending the conference in 2013. Pharmacogenetic testing and precision prescribing are always hot topics that draw…
Read More
The U.S. Department of Veterans Affairs has awarded a Federal Supply Schedule contract to Genelex as a government supplier, which took effect March 15th, 2016. The contract makes pharmacogenetic testing…
Read More
